Top Markets
Coin of the day
MabCure Inc. MabCure Inc.

MabCure Inc.

MBCI
Clasificación en acciones #41406
MabCure Inc., a development stage company, engages in developing and... MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Precio por acción
$0.0003
Última sincronización: 2026-08-12
Capitalización bursátil
$21.97K
Cambio (1 día)
0.00%
Cambio (1 año)
200.00%
País
US
Comercio MabCure Inc. (MBCI)

Categoría

Ratio P/S de MabCure Inc. (MBCI)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de MabCure Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de MabCure Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras